{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:58:31Z","timestamp":1773485911378,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"True North Therapeutics, Inc."}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1111\/ajt.14256","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T21:42:43Z","timestamp":1488404563000},"page":"2300-2311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody\u2013Induced Complement Activation\u2014A Preclinical In Vitro Study"],"prefix":"10.1016","volume":"17","author":[{"given":"M.","family":"Wahrmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"M\u00fchlbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Marinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Regele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Huttary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Eskandary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.F.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"B\u00f6hmig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14256_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I\u2014Molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1111\/ajt.14256_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: A defence system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/ajt.14256_bib3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrneph.2012.212","article-title":"The role of complement in antibody-mediated rejection in kidney transplantation","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/ajt.14256_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.smim.2016.04.007","article-title":"Complement-here, there and everywhere, but what about the transplanted organ?","volume":"28","author":"Montero","year":"2016","journal-title":"Semin Immunol"},{"key":"10.1111\/ajt.14256_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/ajt.14256_bib6","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: A multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/ndt\/gfw027","article-title":"Deceased donor kidney transplantation across donor-specific antibody barriers: Predictors of antibody-mediated rejection","volume":"31","author":"Schwaiger","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.14256_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.2014.166","article-title":"A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection","volume":"87","author":"Sapir-Pichhadze","year":"2015","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.14256_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clinbiochem.2015.05.024","article-title":"Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?","volume":"49","author":"B\u00f6hmig","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1111\/ajt.14256_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/tri.12706","article-title":"Complement inhibition as potential new therapy for antibody-mediated rejection","volume":"29","author":"Eskandary","year":"2016","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.14256_bib11","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: Outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/ajt.14001","article-title":"Eculizumab therapy for chronic antibody-mediated injury in kidney transplant recipients: A pilot randomized controlled trial","volume":"17","author":"Kulkarni","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/ajt.13115","article-title":"The molecular landscape of antibody-mediated kidney transplant rejection: Evidence for NK involvement through CD16a Fc receptors","volume":"15","author":"Venner","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2015.02.004","article-title":"The perfect storm: HLA antibodies, complement, FcgammaRs, and endothelium in transplant rejection","volume":"21","author":"Thomas","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1111\/ajt.14256_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/tri.12396","article-title":"Antibody-mediated rejection despite inhibition of terminal complement","volume":"27","author":"Bentall","year":"2014","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.14256_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/TP.0000000000000592","article-title":"A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14256_bib18","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1111\/ajt.13871","article-title":"Plasma-derived C1 esterase inhibitor for acute antibody-mediated rejection following kidney transplantation: Results of a randomized double-blind placebo-controlled pilot study","volume":"16","author":"Montgomery","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib19","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/ajt.13663","article-title":"C1 inhibitor in acute antibody-mediated rejection nonresponsive to conventional therapy in kidney transplant recipients: A pilot study","volume":"16","author":"Viglietti","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0031-6997(24)01437-6","article-title":"C1-esterase inhibitor: An anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema","volume":"52","author":"Caliezi","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1111\/ajt.14256_bib21","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1182\/blood-2014-02-556027","article-title":"TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins","volume":"123","author":"Shi","year":"2014","journal-title":"Blood"},{"key":"10.1111\/ajt.14256_bib22","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/ajt.13273","article-title":"An anti-C1s monoclonal, TNT003, inhibits complement activation induced by antibodies against HLA","volume":"15","author":"Thomas","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13023-016-0494-z","article-title":"Combined integrated protocol\/basket trial design for a first-in-human trial","volume":"11","author":"Derhaschnig","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1111\/ajt.14256_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-1759(03)00012-7","article-title":"Flow cytometry based detection of HLA alloantibody mediated classical complement activation","volume":"275","author":"Wahrmann","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1111\/ajt.14256_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1111\/ajt.14256_bib26","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.TP.0000441091.47464.c6","article-title":"Complement component C3 activation: The leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads","volume":"97","author":"Schwaiger","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14256_bib27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14256_bib28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.4049\/jimmunol.163.2.1010","article-title":"Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: Enhancement by IFN-gamma and TNF-alpha","volume":"163","author":"Bian","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/ajt.14256_bib29","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.4049\/jimmunol.138.10.3319","article-title":"Activation of cultured human endothelial cells by recombinant lymphotoxin: Comparison with tumor necrosis factor and interleukin 1 species","volume":"138","author":"Pober","year":"1987","journal-title":"J Immunol"},{"key":"10.1111\/ajt.14256_bib30","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.humimm.2016.02.008","article-title":"Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays","volume":"77","author":"Visentin","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1111\/ajt.14256_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14256_bib32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.kint.2015.11.025","article-title":"Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation","volume":"89","author":"Golshayan","year":"2016","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.14256_bib33","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.imbio.2016.05.004","article-title":"Role of the lectin complement pathway in kidney transplantation","volume":"221","author":"Farrar","year":"2016","journal-title":"Immunobiology"},{"key":"10.1111\/ajt.14256_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1744-313X.2012.01147.x","article-title":"The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera","volume":"40","author":"Weinstock","year":"2013","journal-title":"Int J Immunogenet"},{"key":"10.1111\/ajt.14256_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0161-5890(84)90103-2","article-title":"Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: A novel C1q binding assay","volume":"21","author":"Leatherbarrow","year":"1984","journal-title":"Mol Immunol"},{"key":"10.1111\/ajt.14256_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1084\/jem.168.1.127","article-title":"Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q","volume":"168","author":"Bindon","year":"1988","journal-title":"J Exp Med"},{"key":"10.1111\/ajt.14256_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/tan.12537","article-title":"Inter-individual differences in HLA expression can impact the CDC crossmatch","volume":"85","author":"H\u00f6nger","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1111\/ajt.14256_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.imbio.2012.07.012","article-title":"Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis","volume":"217","author":"DeAngelis","year":"2012","journal-title":"Immunobiology"},{"key":"10.1111\/ajt.14256_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1749-6632.1987.tb33051.x","article-title":"Complement activation in extracorporeal circuits","volume":"516","author":"Chenoweth","year":"1987","journal-title":"Ann N Y Acad Sci"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14256","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522251247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522251247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14256\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:17:35Z","timestamp":1761628655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522251247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1600613522251247"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14256","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody\u2013Induced Complement Activation\u2014A Preclinical In Vitro Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}